Cambridge Major Laboratories and AAIPharma To Merge - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Cambridge Major Laboratories and AAIPharma To Merge



Untitled Document Cambridge Major Laboratories, a CMO providing pharmaceutical API development and manufacturing, and AAIPharma Services, a provider of pharmaceutical analytical testing, product development, and manufacturing services, have announced their intent to merge to form a global supplier of integrated chemistry, manufacturing, and control (CMC) services. Financial terms of the merger were not disclosed. The merger is expected to close by the end of October 2013, subject to Hart-Scott-Rodino approval and other closing conditions.

Source: Cambridge Major Laboratories

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here